T. Rowe Price Investment Management Inc. Reduces Position in The Cooper Companies, Inc. $COO

T. Rowe Price Investment Management Inc. decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,047,117 shares of the medical device company’s stock after selling 779,487 shares during the period. T. Rowe Price Investment Management Inc. owned about 4.62% of Cooper Companies worth $741,502,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. New York Life Investment Management LLC grew its holdings in Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares during the period. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. Allworth Financial LP lifted its position in shares of Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. lifted its position in shares of Cooper Companies by 1.3% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after buying an additional 175 shares in the last quarter. Finally, Blue Trust Inc. grew its stake in shares of Cooper Companies by 13.9% during the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after acquiring an additional 185 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Trading Up 1.3%

COO stock opened at $65.91 on Friday. The firm has a fifty day moving average price of $64.50 and a 200 day moving average price of $74.02. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The firm has a market cap of $12.85 billion, a PE ratio of 55.86, a price-to-earnings-growth ratio of 1.70 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the business earned $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

COO has been the subject of several analyst reports. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a report on Wednesday, March 4th. JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Barclays raised their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and an average target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.